Skip to content
OpenCapital
Get started

Delcath Systems DCTH Balance Sheet Statement

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Cash and cash equivalents
$41.3M+223%$2K-100.0%$41.8M+403%$34.41M+133%$12.78M+8.6%
Short-term investments
$47.99M+4.0%$47.58M+129%$47.1M+730%$46.58M+809%$46.12M+200%
Accounts receivable, net
$14.16M+1.6%$11.74M+7.8%$13.75M+98.3%$15.84M+325%$13.94M+791%
Inventories
$9.81M+37.5%$10.25M+47.9%$10.75M+61.8%$10.52M+66.6%$7.13M+96.3%
Raw materials
$5.77M+49.3%$6.48M+68.3%$7.04M+94.6%$7.23M+101%$3.86M+189%
Work in process
$3.09M+35.9%$2.81M+24.3%$2.71M+20.3%$2.34M+8.2%$2.27M+14.6%
Finished goods
$954K-4.4%$966K+17.2%$994K+28.9%$957K+69.7%$998K+216%
Prepaid expenses and other current assets
$7M+59.9%$6.5M+140%$7.21M+449%$6.12M+322%$4.38M+243%
Income taxes receivable
$523K+772%$696K+1,447%$1.1M+1,199%$489K—$60K—
Accrued investment income
$581K+53.3%$499K+299%$709K+7,778%$448K+1,848%$379K+131%
Total current assets
$120.27M+42.6%$119.53M+62.1%$120.62M+318%$113.48M+261%$84.35M+151%
Property and equipment, net
$3.66M+87.4%$3.17M+76.9%$2.72M+57.0%$2.4M+68.8%$1.95M+46.3%
Accumulated depreciation
$5.34M+6.5%$5.25M+5.9%$5.17M+4.4%$5.1M-0.4%$5.02M-1.6%
Operating lease right-of-use assets
$907K-10.7%$936K-9.9%$965K-9.8%$993K-9.1%$1.02M-9.0%
Total assets
$124.84M+43.0%$123.63M+61.4%$124.3M+292%$116.88M+245%$87.32M+142%
Accrued expenses
$2.81M+51.0%$4.25M-16.3%$3.43M+12.3%$2.89M+25.6%$1.86M+18.8%
Operating lease liabilities, current
$92K-16.4%$101K-3.8%$110K+2.8%$116K+12.6%$110K+7.8%
Total current liabilities
$10.7M+102%$10.95M+78.2%$8.01M-62.9%$10.44M-15.1%$5.29M-60.4%
Operating lease liabilities, non-current
$815K-10.0%$835K-10.5%$855K-11.2%$877K-11.3%$906K-10.8%
Operating Lease Liabilities (Total)
$907K-10.7%$936K-9.8%$965K-9.8%$993K-9.1%$1.02M-9.1%
Other non-current liabilities
$615K-31.4%$628K-18.0%$582K+3.4%$578K-8.5%$896K-6.9%
Total liabilities
$845K-24.1%$864K-11.3%$808K-94.1%$802K-95.2%$1.11M-84.4%
Preferred stock
$0—$0—$0—$0—$0—
Common stock
80M0.0%80M+24,069%80M0.0%80M0.0%80M0.0%
Additional paid-in capital
$641.71M+5.2%$639.15M+6.5%$640.57M+19.4%$631.83M+18.3%$609.99M+15.0%
Retained earnings
-$529.92M+0.1%-$528.85M+0.5%-$526.95M+0.2%-$527.78M+0.4%-$530.48M-2.8%
Accumulated other comprehensive income (loss)
$571K+49.9%$575K+601%$875K+7,855%$592K+7,300%$381K+143%
Total stockholders' equity
$112.71M+40.5%$111.22M+61.8%$114.85M+1,240%$104.99M+2,404%$80.23M+449%
Total liabilities and stockholders' equity
$124.84M+43.0%$123.63M+61.4%$124.3M+292%$116.88M+245%$87.32M+142%
Total Cash, Cash Equivalents, and Restricted Cash (Inclusive)
$41.31M+223%$43.45M+34.1%$41.81M+403%$34.42M+133%$12.78M+8.2%
Cash, Cash Equivalents, and Marketable Securities
$47.99M—$47.58M———————
Available For Sale Securities Debt Securities Current
$47.99M+4.0%$47.58M+129%$47.1M+730%$46.58M+809%$46.12M+200%
Other Inventory, Net
$500K—————————
Net Investment in Lease
$907K-10.7%$936K-9.9%$965K-9.8%$993K-9.1%$1.02M-9.0%
Operating lease right-of-use assets
$907K-10.7%$936K-9.9%$965K-9.8%$993K-9.1%$1.02M-9.0%
Property, plant and equipment at cost
$9M+29.2%$8.41M+24.8%$7.88M+18.0%$7.5M+14.7%$6.97M+8.4%
Operating Lease Right-of-Use Assets in Other Assets
$907K-10.7%$936K-9.9%$965K-9.8%$993K-9.1%$1.02M-9.0%
Accrued Manufacturing Costs
$2.81M+51.0%$4.25M+22.4%$3.43M+12.3%$2.89M+25.6%$1.86M+18.8%
Other Commercial Liabilities
$7.14M+101%$8.19M+61.3%$5.77M+1.1%$5.6M+26.8%$3.56M-19.0%
Accrued Liabilities, Current
$7.14M+101%$8.19M+61.3%$5.77M+1.1%$5.6M+26.8%$3.56M-19.0%
Compensation and benefits
$2.81M+51.0%$4.25M+22.4%$3.43M+12.3%$2.89M+25.6%$1.86M+18.8%
Lease Liability Payments - 2020 (Remaining Three Months)
$123K-12.1%——$48K+2.1%$96K+3.2%$140K0.0%
Operating Lease Liability Payments - 2024 (Lessee)
$152K+2.7%——$148K-12.9%$148K-12.4%$148K-12.4%
Operating Lease Liability Payments - 2025 (Lessee)
$158K+0.6%——$157K+3.3%$157K+2.6%$157K+2.6%
Lease Liability Payments - Due Year Two
$152K+2.7%——$148K-12.9%$148K-12.4%$148K-12.4%
Lease Liability Payments - Due Year Three
$157K+3.3%——$152K+2.7%$152K+2.7%$152K+2.7%
Lease Liability Payments - Due Year Four
$158K+0.6%——$157K+3.3%$157K+2.6%$157K+2.6%
Lease Liability Payments - Remainder of Fiscal Year
$148K-12.9%——$171K-9.5%$171K-8.6%$170K-9.1%
Operating Lease Liability Payments Due
$1.22M-13.2%——$1.32M-12.4%$1.37M-11.8%$1.41M-11.7%
Operating Lease Liability - Undiscounted Excess Amount
$317K-19.5%——$354K-18.8%$374K-18.3%$394K-17.7%
Professional Service Fees Payable
$1.36M+322%$736K+1,191%$251K+43.4%$305K+84.8%$321K+27.4%
Contingent Consideration Liability (Non-Current)
$845K-24.1%$864K-11.3%$808K+2.9%$802K+6.9%$1.11M+14.3%
Operating Lease Liability Payments - 2026 (Lessee)
$157K+3.3%——$152K+2.7%$152K+2.7%$152K+2.7%
Operating Lease Liability Payments - 2027 (Lessee)
$157K+3.3%——$152K+2.7%$152K+2.7%$152K+2.7%
Operating Lease Liability Payments - 2028 (Lessee)
$158K+0.6%——$157K+3.3%$157K+2.6%$157K+2.6%
Total debt
$907K-10.7%$936K-9.8%$965K-68.6%$993K-82.2%$1.02M-88.0%
Common Stock Par Value Per Share
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
Common Stock Shares Issued
34.5M+3.1%34.7M+4.9%35.3M+26.0%35M+25.1%33.4M+31.4%
Common Stock Shares Outstanding
$13.93M-56.3%$17.39M-39.6%$20.18M+30.6%$35.67M+176%$31.86M+7,258%
Convertible Preferred Stock Authorized Shares
10M0.0%10M0.0%10M0.0%10M0.0%10M0.0%
Convertible Preferred Stock Issued Shares
14.2K0.0%14.2K0.0%14.2K+15.0%14.2K+15.0%14.2K-15.6%
Convertible Preferred Stock Outstanding Shares
14.2K0.0%14.2K0.0%14.2K+15.0%14.2K+15.0%14.2K-15.6%
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
$344K+3.0%$347K+4.8%$353K+26.1%$350K+25.4%$334K+31.5%
Preferred stock; $0.001 par value; 100 shares authorized; no shares issued and outstanding
$0—$0—$0—$0—$0—
Number of Exercisable Options
5.4M+39.8%——4.4M+29.4%4.2M+41.7%3.9M+50.8%
Preferred Stock Par Value Per Share
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
Share-Based Payment Award Options Outstanding - Number
8.6M+8.2%7.8M+35.0%7.7M+27.9%8.1M+31.8%8M+31.9%
Share-Based Payment - Unrecognized Cost of Nonvested Awards
$20.9M-19.0%——$16.1M+156%$21.2M+155%$25.8M+150%
Share Repurchase Authorization Limit
$16M—————————
Share Repurchase Program - Amount Remaining
$16M—————————
Weighted Average Exercise Price of Outstanding Options
$10.00+1.9%$10.05+39.0%$10.06+39.9%$10.01+40.8%$9.81+38.2%
Cumulative Cost Basis
$9M+29.2%$8.41M+24.8%$7.88M+18.0%$7.5M+14.7%$6.97M-54.1%
Clinical expenses
$2.1M+201%$2.07M+236%$1.18M+37.1%$1.1M+161%$697K-34.5%
Inventory
$28K+211%$74K+68.2%$102K+1,175%$222K+2,675%$9K-25.0%
Professional service fees
$1.36M+322%$736K+1,191%$251K+43.4%$305K+84.8%$321K+27.4%
Available for sale investments
$47.99M—$47.58M———————
Business Combination, Contingent Consideration, Liability
$845K-24.1%$864K-11.3%$808K+2.9%$802K+6.9%$1.11M+14.3%
Cash and cash equivalents, end of period
$41.31M+223%$43.45M+34.1%$41.81M+403%$34.42M+133%$12.78M+8.2%
Common stock, par value (in dollars per share)
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
Common stock, shares authorized (in shares)
$80M0.0%$80M0.0%$80M0.0%$80M0.0%$80M0.0%
Common stock, shares issued (in shares)
$34.47M+3.1%$34.69M+4.9%$35.31M+26.0%$34.96M+25.1%$33.44M+31.4%
Common Stock, Shares, Outstanding
$34.47M+3.1%$34.69M+4.9%$35.31M+26.0%$34.96M+25.1%$33.44M+31.4%
Unrecognized compensation cost related to non-vested awards
$20.9M-19.0%——$16.1M+156%$21.2M+155%$25.8M+150%
ESPP withholding
$198K+58.4%$396K+65.0%$202K—$255K—$125K—
Interest receivable on interest rate and cross currency swaps
$581K+53.3%$499K+299%$709K+7,778%$448K+1,848%$379K+131%
Raw materials
$5.77M+49.3%$6.48M+68.3%$7.04M+94.6%$7.23M+101%$3.86M+189%
Lessee Operating Lease Liability Payments Due
$1.22M-13.2%——$1.32M-12.4%$1.37M-11.8%$1.41M-11.7%
Thereafter
$486K-24.4%——$643K-19.6%$643K-19.6%$643K-19.6%
Lessee Operating Lease Liability Undiscounted Excess Amount
$317K-19.5%——$354K-18.8%$374K-18.3%$394K-17.7%
Milestone payment unpaid
——————————
Pre-funded warrants outstanding (in shares)
1.3M0.0%——1.3M+81.9%1.3M+81.9%1.3M-34.4%
Other accrued liabilities
$652K+98.8%$437K-1.4%$379K-51.0%$611K-16.4%$328K-56.1%
medac
$0-100%$235K+13.0%$225K—$224K—$217K—
Preferred Stock, Par or Stated Value Per Share
$0.010.0%$0.010.0%$0.010.0%$0.010.0%$0.010.0%
Preferred Stock, Shares Authorized
$10M0.0%$10M0.0%$10M0.0%$10M0.0%$10M0.0%
Preferred stock, shares designated (in shares)
179.7K0.0%——179.7K0.0%179.7K0.0%179.7K0.0%
Preferred Stock, Shares Issued
$14.19K0.0%$14.19K0.0%$14.19K+15.0%$14.19K+15.0%$14.19K-15.6%
Preferred Stock, Shares Outstanding
$14.19K0.0%$14.19K0.0%$14.19K+15.0%$14.19K+15.0%$14.19K-15.6%
Clinical trial expenses
$2.45M+103%$2.41M+983%$2.41M+983%$2.41M+983%$1.21M+444%
Prepaid Insurance
$557K+101%$547K+240%$180K+60.7%$188K+29.7%$277K+60.1%
Licenses
$538K-46.0%$613K-38.1%$682K+161%$498K—$996K—
Professional services
$941K+14.6%$804K+5.5%$1.06M+182%$1.25M+90.1%$821K+147%
Software
$1.07M+570%$706K+330%$670K+644%$404K—$160K—
Aggregate Intrinsic Value, Unvested
$2.54M-81.3%——$6.49M-33.5%$12.7M+34.3%$13.6M+3,700%
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
$5.42M+39.8%——$4.37M+29.4%$4.24M+41.7%$3.87M+50.8%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number
$8.62M+8.2%$7.79M+35.0%$7.75M+27.9%$8.08M+31.8%$7.97M+31.9%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price
$10+1.9%$10.05+39.0%$10.06+39.9%$10.01+40.8%$9.81+38.2%
Weighted Average Exercise Price, Unvested (in dollars per share)
$11.69+4.7%——$11.88+119%$11.61+117%$11.17+109%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value
$13.93M-56.3%$17.39M-39.6%$20.18M+30.6%$35.67M+176%$31.86M+7,258%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price
$9+7.5%——$8.64+0.6%$8.57-4.2%$8.37-11.6%
Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares
3.2M-21.7%——3.4M+26.0%3.8M+22.4%4.1M+18.0%
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value
$11.39M-37.6%——$13.69M+141%$22.97M+567%$18.26M+24,573%
Share Repurchase Program, Authorized, Amount
——$25M———————
Share Repurchase Program, Remaining Authorized, Amount
$16M—————————
Remainder of Fiscal Year 2024
$123K-12.1%——$48K+2.1%$96K+3.2%$140K0.0%
Unrecorded Unconditional Purchase Obligation
$2.5M0.0%——$2.5M—$2.1M—$2.5M—

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Delcath Systems's total assets?
Delcath Systems (DCTH) holds $124.8M in total assets, up 43.0% year over year.
How much debt does Delcath Systems have?
Delcath Systems carries $907.0K in total debt against $112.7M of shareholders' equity, a debt-to-equity ratio of 0.01.
How much cash does Delcath Systems have?
Delcath Systems holds $41.3M in cash and equivalents.
Can Delcath Systems cover its short-term obligations?
Its current ratio is 11.24 — current assets exceed current liabilities.
Where does Delcath Systems's balance sheet data come from?
Every line is extracted from Delcath Systems's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.